Hitasha Rupani

2.1k total citations
53 papers, 665 citations indexed

About

Hitasha Rupani is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Hitasha Rupani has authored 53 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Physiology, 25 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Hitasha Rupani's work include Asthma and respiratory diseases (34 papers), Respiratory and Cough-Related Research (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Hitasha Rupani is often cited by papers focused on Asthma and respiratory diseases (34 papers), Respiratory and Cough-Related Research (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Hitasha Rupani collaborates with scholars based in United Kingdom, United States and Japan. Hitasha Rupani's co-authors include Peter Howarth, Tilman Sánchez-Elsner, Rocío T. Martínez-Núñez, Ramesh Kurukulaaratchy, Laurie C.K. Lau, Brian D. Kent, Anoop Chauhan, Nivenka Jayasekera, Donna E. Davies and Thomas Brown and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hitasha Rupani

42 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitasha Rupani United Kingdom 14 340 256 195 167 127 53 665
Stelios Pavlidis United Kingdom 12 373 1.1× 299 1.2× 256 1.3× 137 0.8× 33 0.3× 29 673
Brian D. Modena United States 13 389 1.1× 206 0.8× 243 1.2× 176 1.1× 26 0.2× 26 770
Nobutaka Edakuni Japan 14 286 0.8× 336 1.3× 95 0.5× 115 0.7× 24 0.2× 46 573
Zhiwei Xu China 15 122 0.4× 145 0.6× 94 0.5× 118 0.7× 49 0.4× 29 528
Paul Rugman United Kingdom 10 470 1.4× 407 1.6× 271 1.4× 131 0.8× 17 0.1× 21 776
Emma Doran United Kingdom 9 352 1.0× 129 0.5× 333 1.7× 76 0.5× 11 0.1× 14 643
Irma Mahmutovic Persson Sweden 10 139 0.4× 107 0.4× 130 0.7× 75 0.4× 14 0.1× 30 345
Rochelle Palmay New Zealand 9 507 1.5× 373 1.5× 145 0.7× 53 0.3× 14 0.1× 10 610
Kimihiro Takeyabu Japan 10 160 0.5× 309 1.2× 54 0.3× 71 0.4× 79 0.6× 19 466
Chun‐Liang Chou Taiwan 12 76 0.2× 120 0.5× 262 1.3× 175 1.0× 34 0.3× 26 607

Countries citing papers authored by Hitasha Rupani

Since Specialization
Citations

This map shows the geographic impact of Hitasha Rupani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitasha Rupani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitasha Rupani more than expected).

Fields of papers citing papers by Hitasha Rupani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitasha Rupani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitasha Rupani. The network helps show where Hitasha Rupani may publish in the future.

Co-authorship network of co-authors of Hitasha Rupani

This figure shows the co-authorship network connecting the top 25 collaborators of Hitasha Rupani. A scholar is included among the top collaborators of Hitasha Rupani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitasha Rupani. Hitasha Rupani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Ernie, et al.. (2025). Pregnancy, asthma and exacerbations: a population-based cohort. European Respiratory Journal. 66(6). 2501327–2501327. 1 indexed citations
2.
Busby, John, Adel Mansur, Mitesh Patel, et al.. (2025). Long-Term Clinical Remission on Biologics: An Analysis of Real-World Data From the UK Severe Asthma Registry. The Journal of Allergy and Clinical Immunology In Practice. 14(2). 436–444.e5.
3.
Jackson, David J., Hassan Burhan, Hitasha Rupani, et al.. (2024). Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two‐Year Real‐World Data With Benralizumab. Clinical & Experimental Allergy. 54(10). 734–746. 10 indexed citations
4.
Rupani, Hitasha, William W. Busse, Peter Howarth, et al.. (2024). Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma. Allergy. 79(10). 2589–2604. 7 indexed citations
5.
Rupani, Hitasha, Rekha Chaudhuri, Steven J. Smith, et al.. (2024). Preserved antibody responses to COVID-19 vaccination and lower odds of developing COVID-19 in adults with severe asthma. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2510–2513.e2.
6.
Levy, Mark L, Richard Beasley, Toby Capstick, et al.. (2024). A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy. British Journal of General Practice. 74(739). 86–89. 1 indexed citations
7.
Pfeffer, Paul, Thomas Brown, Rekha Chaudhuri, et al.. (2024). Impact of comorbidities on EQ-5D quality-of-life index in severe asthma. SHILAP Revista de lepidopterología. 3(3). 100286–100286.
8.
Jackson, David J., Matthew A. Coleman, G d’Ancona, et al.. (2024). An international consensus on the use of asthma biologics in pregnancy. The Lancet Respiratory Medicine. 13(1). 80–91. 9 indexed citations
9.
Cook, Peter C., Hans Michael Haitchi, Ramesh Kurukulaaratchy, et al.. (2023). Benralizumab treatment of severe asthma in pregnancy: A case series. The Journal of Allergy and Clinical Immunology In Practice. 11(9). 2919–2921. 5 indexed citations
10.
Rupani, Hitasha, Adnan Azim, Anna Freeman, et al.. (2023). Comprehensive Characterization of Difficult-to-Treat Asthma Reveals Near Absence of T2-Low Status. The Journal of Allergy and Clinical Immunology In Practice. 11(9). 2812–2821.e4. 18 indexed citations
12.
Fox, Lauren, Laura Wiffen, Alexander Hicks, et al.. (2021). The VICTORY (Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions) Study: Protocol for a Cross-sectional Observational Study. JMIR Research Protocols. 10(7). e23831–e23831. 4 indexed citations
13.
Maguire, Roma, John Connaghan, Anne Arber, et al.. (2020). Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods Study. Journal of Medical Internet Research. 22(11). e19180–e19180. 19 indexed citations
14.
Fogg, Carole, Thomas Brown, Hitasha Rupani, et al.. (2019). Modern Innovative Solutions to Improve Outcomes in Asthma, Breathlessness, and Chronic Obstructive Pulmonary Disease (MISSION ABC): Protocol for a Mixed-Methods Study. JMIR Research Protocols. 8(3). e9228–e9228. 5 indexed citations
15.
Rupani, Hitasha & Anoop Chauhan. (2019). Measurement of FeNO in asthma: what the hospital doctor needs to know. British Journal of Hospital Medicine. 80(2). 99–104. 6 indexed citations
16.
Martínez-Núñez, Rocío T., Hitasha Rupani, Manuela Platé, et al.. (2018). Genome-Wide Posttranscriptional Dysregulation by MicroRNAs in Human Asthma as Revealed by Frac-seq. The Journal of Immunology. 201(1). 251–263. 22 indexed citations
17.
Rupani, Hitasha, Rocío T. Martínez-Núñez, Patrick Dennison, et al.. (2016). Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile. American Journal of Respiratory and Critical Care Medicine. 194(1). 26–37. 50 indexed citations
18.
Brown, Thomas, Hitasha Rupani, Clair Barber, et al.. (2014). Dissociation between clinical trial inclusion and exclusion criteria for trials in severe asthma and the reality of the patient population. European Respiratory Journal. 44(Suppl 58). P3326–P3326. 2 indexed citations
19.
Rupani, Hitasha, Laurie Lau, Junya Ono, et al.. (2014). Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma. European Respiratory Journal. 44(Suppl 58). P3986–P3986. 2 indexed citations
20.
Rupani, Hitasha, Tilman Sánchez-Elsner, & Peter Howarth. (2012). MicroRNAs and respiratory diseases. European Respiratory Journal. 41(3). 695–705. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026